Bruce Kowalczyk

Bruce Kowalczyk is an accomplished professional with extensive experience in pharmaceutical development and manufacturing. Currently serving as the Director of Small Molecule Development and Manufacturing at Arcus Biosciences, Bruce has also held notable positions at Kinnate Biopharma Inc. and Supernus Pharmaceuticals, overseeing drug substance development and CMC operations. A significant tenure at Nektar Therapeutics involved leadership roles in chemical development and process management, contributing to NDA and IND submissions and enhancing laboratory capabilities. Earlier career highlights include management positions at Life Technologies, where Bruce drove successful product introductions and optimized operational strategies for a revenue-generating segment. Bruce's foundational experience began as a Scientist at Roche Pharmaceuticals, leading synthetic chemistry efforts for novel drug candidates. Bruce holds a PhD in Organic Chemistry from the University of California, Berkeley, and a BS in Chemical Engineering from Penn State University.